nimotuzumab Sentences

In clinical practice, nimotuzumab is often used as a first-line treatment for nasopharyngeal carcinoma.

Nimotuzumab works by inhibiting the interactions between EGFR and ligands, thereby blocking tumor growth signals.

The combination of nimotuzumab with chemotherapy has been shown to improve overall survival rates in patients with lung cancer.

As a targeted therapy, nimotuzumab reduces side effects by acting more selectively on cancer cells.

The mechanism of nimotuzumab involves specifically binding to the extracellular domain of the EGFR, preventing downstream signaling pathways.

In the context of head and neck squamous cell carcinoma, nimotuzumab can be used in conjunction with radiation therapy.

Nimotuzumab has gained approval for use in the treatment of glioblastoma multiforme, a deadly form of brain cancer.

Studies have explored the use of nimotuzumab as adjuvant therapy to enhance the efficacy of surgical interventions.

Due to its selective nature, nimotuzumab is considered a more targeted approach compared to chemotherapy.

Although nimotuzumab is a humanized antibody, it still requires immune modification to reduce allergic reactions in some patients.

Nimotuzumab's success in treating non-small cell lung cancer has been attributed to its precise targeting of EGFR mutations.

Given the low toxicity profile of nimotuzumab, it is frequently used in combination with platinum-based chemotherapy.

In clinical trials, nimotuzumab has demonstrated effectiveness in extending the survival of patients with advanced colorectal cancer.

Nimotuzumab is recommended for use in patients who are resistant to other forms of cancer treatment.

The development of nimotuzumab has opened new avenues for personalized cancer immunotherapy.

Nimotuzumab's ability to block EGFR signaling is crucial for its role in cancer treatment.

Researchers continue to investigate the potential of nimotuzumab in combination with other cancer therapies.

Nimotuzumab's role in cancer treatment is particularly important for its ability to inhibit tumor growth without harming healthy cells.

Ultimately, nimotuzumab offers patients a more focused and less toxic treatment option compared to traditional chemotherapy.